General Manager, U.S. Business Unit
Mohamed Ladha was appointed General Manager, U.S. Business Unit in September 2020 and leads the day to day operations and commercialization of the Oncopeptides Oncology portfolio for the US region. Before Mohamed joined Oncopeptides he spent over 17 years extensively in the fields of oncology and specialty care including leading sales, marketing, market access, commercial operations and medical affairs teams at pharmaceutical and biotechnology companies.
Prior to joining Oncopeptides, Mohamed served as VP and Head of Commercial & Medical Affairs at Tocagen, a cancer-selective immuno-gene therapy company. Prior to this he led the U.S. lung cancer franchise portfolio at Takeda Oncology, and oversaw the U.S. and global lung cancer franchise portfolio at ARIAD Pharmaceuticals, today part of Takeda Oncology.
Mohamed brings extensive commercial leadership and launch experience within oncology from his roles as General Manager of Biosimilars Business at Pfizer/Hospira, Global Brand/Portfolio Lead and Commercial Development at Schering-Plough/Merck.